We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 20.18%
2 Consumer Discretionary 14.97%
3 Financials 14.24%
4 Technology 12.89%
5 Industrials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SON icon
1526
Sonoco
SON
$5.77B
$1.92M ﹤0.01%
38,615
-2,188
-5% -$104K
FRGI
1527
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$1.9M ﹤0.01%
86,910
-10,700
-11% -$302K
NSM
1528
DELISTED
Nationstar Mortgage Holdings
NSM
$1.87M ﹤0.01%
166,300
+34,300
+26% +$398K
OC icon
1529
Owens Corning
OC
$12.3B
$1.87M ﹤0.01%
36,263
+6,919
+24% +$345K
ATW
1530
DELISTED
Atwood Oceanics
ATW
$1.86M ﹤0.01%
148,900
-14,400
-9% -$150K
DHC
1531
Diversified Healthcare Trust
DHC
$2.02B
$1.86M ﹤0.01%
89,148
+29,346
+49% +$547K
FSBW icon
1532
FS Bancorp
FSBW
$325M
$1.84M ﹤0.01%
+145,580
New +$1.83M
MIC
1533
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$1.84M ﹤0.01%
24,857
+1,915
+8% +$135K
ORI icon
1534
Old Republic International
ORI
$10.3B
$1.83M ﹤0.01%
95,075
+197
+0.2% +$3.68K
RAX
1535
DELISTED
Rackspace Hosting Inc
RAX
$1.79M ﹤0.01%
85,728
+7,413
+9% +$173K
CNI icon
1536
Canadian National Railway
CNI
$76.4B
$1.78M ﹤0.01%
30,320
-1,300
-4% -$78.4K
SPN
1537
DELISTED
Superior Energy Services, Inc.
SPN
$1.78M ﹤0.01%
9,683
-1,055
-10% -$172K
KALV
1538
DELISTED
KalVista Pharmaceuticals
KALV
$1.78M ﹤0.01%
191,993
ARC
1539
DELISTED
ARC Document Solutions, Inc.
ARC
$1.78M ﹤0.01%
457,851
-988,370
-68% -$4.03M
ACM icon
1540
Aecom
ACM
$8.19B
$1.77M ﹤0.01%
55,872
+8,629
+18% +$273K
LINDW
1541
DELISTED
Lindblad Expeditions Holdings Inc. Warrant
LINDW
$1.77M ﹤0.01%
886,585
NUAN
1542
DELISTED
Nuance Communications, Inc.
NUAN
$1.77M ﹤0.01%
130,825
+11,058
+9% +$164K
IM
1543
DELISTED
Ingram Micro
IM
$1.77M ﹤0.01%
50,849
+5,000
+11% +$174K
SUI icon
1544
Sun Communities
SUI
$14.6B
$1.76M ﹤0.01%
22,979
-56,267
-71% -$3.97M
HLF icon
1545
Herbalife
HLF
$1.28B
$1.75M ﹤0.01%
59,734
-978
-2% -$29.3K
ARW icon
1546
Arrow Electronics
ARW
$10.6B
$1.73M ﹤0.01%
27,983
+103
+0.4% +$6.54K
NSTG
1547
DELISTED
NanoString Technologies, Inc.
NSTG
$1.72M ﹤0.01%
136,670
+12,431
+10% +$180K
AMCX icon
1548
AMC Global Media
AMCX
$485M
$1.72M ﹤0.01%
28,462
+210
+0.7% +$13.4K
CNO icon
1549
CNO Financial Group
CNO
$5.02B
$1.72M ﹤0.01%
98,238
-6,000
-6% -$113K
RIO icon
1550
Rio Tinto
RIO
$160B
$1.72M ﹤0.01%
54,800

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.